News from BioWorld A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 25, 2013, 13:37 ET

BioWorld Today, Medical Device Daily Honored as Best Daily Publications

 In an international competition sponsored by the Specialized Information Publishers Association (SIPA), BioWorld Today and Medical Device...

Apr 29, 2013, 13:10 ET

BioWorld® Today to Host Webinar on the Royalty Financing Market

 BioWorld® Today, biotech's top news source, today announced it will be hosting a webinar titled "Royalty Financing for Biotech and...

Apr 08, 2013, 11:23 ET
BioWorld.  (PRNewsFoto/BioWorld)

In Q1 Public Biopharmas Shift Fundraising into Overdrive

 Biotech companies generated $5 billion in the first quarter of 2013, just 3% less than the $5.15 billion raised in the first quarter last...

Feb 27, 2013, 11:57 ET
BioWorld.  (PRNewsFoto/BioWorld)

Recall of Anemia Drug Omontys Rings Alarm Over Biosimilars

 Makers of innovative biologics have legitimate reason to sound alarms about automatic substitution of biosimilars that have not proven their...

Jan 24, 2013, 09:49 ET
BioWorld.  (PRNewsFoto/BioWorld)

Tsunami of Coming Biosimilars Set to Shake up Drug Development Game

 The quiet but growing flood of biosimilars ‑ new versions of existing biopharmaceutical drugs ‑ promises to reduce the overall...

Dec 27, 2012, 11:34 ET
BioWorld.  (PRNewsFoto/BioWorld)

BioWorld's Top 10 Most Impactful Biopharmaceutical Stories of 2012

 Biotechnology played a pivotal role in the development of more targeted drugs in 2012 as the science continues to elucidate the molecular...

Nov 14, 2012, 12:22 ET
BioWorld.  (PRNewsFoto/BioWorld)

Royalty Rates Take Center Stage in Biopharma Dealmaking

One-by-one, big pharmaceutical firms are plunging off patent cliffs. They're scrambling to fill pipelines and reinforce bottom lines. The door is...

Oct 03, 2012, 12:09 ET
BioWorld.  (PRNewsFoto/BioWorld)

What Global Financial Crisis? Capital Markets Back Biotechs

Biopharmaceutical drugmakers have made up for a sluggish start to 2012 ‑ despite turbulence in the global capital markets ‑ to perform...

Sep 19, 2012, 15:39 ET
BioWorld.  (PRNewsFoto/BioWorld)

Biotech Executive Salaries Continue to Rise Despite Weak Economy

Amgen CEO Kevin Sharer, at $1.75 million in his final year before retirement, led the list of highest-salaried biotechnology executives in 2011,...

Aug 22, 2012, 10:23 ET
BioWorld.  (PRNewsFoto/BioWorld)

BioWorld Launches Enhanced Biopharma News Site with Data, Analysis

 Biopharmaceutical industry insiders know that news about the world's most innovative drugs in development has always come from BioWorld....

Jul 09, 2012, 12:20 ET
BioWorld.  (PRNewsFoto/BioWorld)

Tougher Times May be Ahead for Biotechs: 1H12 Fundraising Slows

The amount of capital generated by private and public biotech companies slowed dramatically in the first half of 2012, with $7.9 billion raised,...

Jun 28, 2012, 15:07 ET
BioWorld.  (PRNewsFoto/BioWorld)

Obamacare Ruling, Other Pivotal News Rocks Biotech Sector in June

From today's Supreme Court ruling that upholds the Affordable Care Act (ACA) to the FDA's approval of the first new obesity drug in 13 years, June...

Apr 25, 2012, 09:00 ET

Biopharma M&A Trends Hold Steady, But Deals Declined in 2011

Given the narrow initial public offering window, declining venture investments and tough capital markets, mergers and acquisitions (M&A) have...

Nov 02, 2011, 16:10 ET

BioWorld Launches Enhanced Website

Biopharmaceutical industry insiders know that news about the world's most innovative drugs in development has always come from BioWorld. BioWorld's...

Mar 31, 1998, 00:00 ET

BioWorld Tracks Progress of Biotechnology In 312-Page Comprehensive Annual Report

ATLANTA, March 31 /PRNewswire/ -- In 1997, biotechnology's name recognition soared on the heels of Dolly, but the industry recorded only an...